‘Compassionate use’ of molnupiravir would dramatically reduce Covid-19’s toll. With the stroke of a pen, the Food and Drug Administration could save thousands of Covid patients’ lives. Data released last week showed that the new antiviral pill molnupiravir, made by Merck and Ridgeback Biotherapeutics, is safe and reduces the risk of the